frequency of migraine in the general population, care must be taken when including migrainelike headache as part of this syndrome. The case series reported in the workshop proceedings 8 had a highly variable prevalence of migraine. Others (Verin) identify them with great frequency and still others (Chabriat, France) with an intermediate frequency. Depression is common in early dementia, and it may be no more unique to this illness than to other dementias. These questions need prospective, critical analysis to avoid the development of an inaccurate phenotype and consequent misdiagnosis. A variety of other conditions, including the coagulopathies, MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes), Fabry's disease, abnormal lipoproteinemias, cerebral amyloid angiopathy, and homocystinuria, have all been ruled out in these pedigrees.
The histopathology within the white matter is consistent. The most notable changes are multiple small infarcts in the basal ganglia, thalamus, periventricular white matter, and pons. 1014 There is variable cortical and central white-matter atrophy with diffuse myelin loss and pallor of the hemispheric white matter. 18 Other ischemic changes include ischemic cell changes in the third cortical layer of the frontal and temporal cortex, with neuronal loss and astrocytic proliferation. 10 These changes are closely reminiscent of those described in cases of subcortical ischemia associated with hypertension, 19 -20 and some aspects of the histopathology are similar to those described in leukoaraiosis, 21 -22 especially the white-matter atrophy with diffuse myelin loss.
The vascular changes are widespread but are most prominent in the small muscular arteries and arterioles, especially in the pia-arachnoid, basal ganglia, thalamus, mesencephalon, pons, and cerebellum. The most common changes are concentric thickening of the vascular wall and narrowing of the lumen by either subendothelial fibrous proliferation or smudgy hyaline degeneration of the intima, 18 sometimes extending to the whole thickness of the wall. Reduplication and fragmentation of the internal elastic lamina is seen. mucopolysaccharides (acid glycosaminoglycans). 10 In three additional possible cases, staining with Alcian blue was positive. 23 However, none of the histopathologic reports in cases of hypertension-associated subcortical ischemia state that staining for PAS was performed. In five cases of vascular dementia with smallvessel disease stained with Alcian blue at low pH, similar material was seen in the walls of the vessels (S. Gaytan, D. Munoz, V. Hachinski, unpublished data, 1994). Consequently, the absence of reports of PAS staining in hypertension-associated white-matter disease may be misleading. Whether this material is pathogenic or simply a consequence of some other process remains unsettled. Clarification will require, at the very least, identification of the material. Heparan sulfate in the cerebral vessel walls has been suggested. 25 Within the Japanese literature there is a second condition, possibly of autosomal recessive inheritance, in which cerebrovascular disease is a predominant finding, along with thin, aged-appearing skin. Intervertebral disk disease and spinal deformity at an early age may also be common features. 26 -28 Alopecia follows after the neurological presentation, which is similar to that described for CADASIL.
26 w The histopathology is also similar to that for CADASIL, although there is no mention of a PAS-positive eosinophilic deposit in the media of the affected vessels.
27
- 28 These cases are clearly different from CADASIL and reflect a second genetic condition (CARASIL?) with a seemingly direct effect upon the cerebral vasculature.
While the PAS-positive material may prove not to be a hallmark of CADASIL, CADASIL appears to be a vascular disease and not one of the white matter. Given the young age of the patients with CADASIL, the even younger asymptomatic subjects who are MRI positive, and the detailed investigation in some series, it is clear that there are no other coexistent conditions. Ischemia must therefore be the basis of the white-matter changes. How do they arise? Some lesions are clearly infarcts attributable to occluded vessels, but what of the rest? Chronic ischemia does not occur in the deep white matter in hypertension-associated subcortical ischemia, as the decreased blood flow is coupled with decreased metabolism. 30 If such patients are given acetazolamide, a vasodilator, they do not exhibit the increase in regional cerebral blood flow seen in normal elderly individuals, which suggests that these patients have decreased perfusion reserve. 31 To translate this into a pathophysiological mechanism for the white-matter changes, it has been postulated that these patients undergo episodic hypotension, causing ischemia in the zones of decreased perfusion reserve, and that the patterns of white-matter change seen could be caused by modest decreases in perfusion of this kind. 21   -32   -33 There is, however, no conclusive evidence. Limited to CADASIL, the question is important to a few individuals. However, leukoaraiosis, some of which may occur on the same hemodynamic basis as CADASIL, is increasingly being identified by MRI 34 -37 and may be treatable if a hemodynamic disturbance in addition to small-vessel disease can be shown to be the mechanism.
Two new genetic diseases affecting the small vessels of the brain, one autosomal dominant and one recessive, have recently been described. It will be of interest to see whether they shed any light on small-vessel cerebrovascular disease in general. In response to hypertension some, but importantly not all, individuals develop the pattern of a small-vessel disease termed lipohyalinosis. With this, white-matter changes occur that may in some be the basis of vascular cognitive impairment. 38 We speculate that these individuals also have a genetic predisposition to small-vessel disease that manifests itself in the presence of other risk factors for vascular disease. This could be clarified by carrying out familial studies in cases in which neuroimaging has identified leukoaraiosis in relatively young subjects. Whether any such predisposition is directly related to CADASIL, perhaps as a different defect in the same gene, will require further study. The relationship between the PAS/Alcian blue staining material and small-vessel disease in cases of leukoaraiosis of all causes needs to be clarified. If the material is always associated with cerebral small-vessel disease, what is its origin? Is it pathogenetic or merely a consequence of some other process? If the material is important, how is it related to the genetic abnormality?
The description and genetic identification of CADASIL represents a clinical and scientific triumph, combining the best of European classical neurology with the latest molecular technologies. The significance of the findings goes well beyond the condition itself. It paves the way for research into pathophysiology and encourages the search for related or less manifest disorders. It also represents an important step in elucidating the genetics of cerebrovascular disease, which are bound to play an increasingly important role. CADASIL represents a magnificent beginning.
